Efficacy and safety of mirogabalin in patients with fibromyalgia: protocol for a multicentre, Prospective, Randomised, Open-label, Blinded Endpoint (PROBE) study.

Liu M, Li Y, Yao X, Liang Y, Mao P, Huang Y, Zhang C, Li Y, Li C, Ma K, Li S, Zhang D, Luo F, Fan B

Open source

DOI
10.1136/bmjopen-2025-110911
Published
2026 Aug 25
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-110911,
  title = {Efficacy and safety of mirogabalin in patients with fibromyalgia: protocol for a multicentre, Prospective, Randomised, Open-label, Blinded Endpoint (PROBE) study.},
  author = {Liu M and Li Y and Yao X and Liang Y and Mao P and Huang Y and Zhang C and Li Y and Li C and Ma K and Li S and Zhang D and Luo F and Fan B},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2025-110911},
  url = {https://doi.org/10.1136/bmjopen-2025-110911}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of mirogabalin in patients with fibromyalgia: protocol for a multicentre, Prospective, Randomised, Open-label, Blinded Endpoint (PROBE) study.
AU  - Liu M
AU  - Li Y
AU  - Yao X
AU  - Liang Y
AU  - Mao P
AU  - Huang Y
AU  - Zhang C
AU  - Li Y
AU  - Li C
AU  - Ma K
AU  - Li S
AU  - Zhang D
AU  - Luo F
AU  - Fan B
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2025-110911
UR  - https://doi.org/10.1136/bmjopen-2025-110911
ER  - 

APA

M, L., Y, L., X, Y., Y, L., P, M., Y, H., C, Z., Y, L., C, L., K, M., S, L., D, Z., F, L., & B, F. (2026). Efficacy and safety of mirogabalin in patients with fibromyalgia: protocol for a multicentre, Prospective, Randomised, Open-label, Blinded Endpoint (PROBE) study.. BMJ open. https://doi.org/10.1136/bmjopen-2025-110911

Source records